Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Fixed Combination Orphenadrine, Acetaminophen, Caffeine, and Diclofenac in Acute Low Back Pain
NCT02985671Phase 3Unknown
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Jan 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of orphenadrine, acetaminophen, caffeine and diclofenac in mechanical low back pain (2 arms), sponsored by Aché Laboratórios Farmacêuticos. Primary endpoint: Superiority of the fixed association compared to Voltaren® in the treatment of the acute mechanical postural low back pain at 72 hours. Status: unknown.
02
Drugs
orphenadrineacetaminophencaffeinediclofenac
03
Conditions
mechanical low back pain
Beyond the preview
Go deeper on NCT02985671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985671.